ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Sonablate raised $200 million in funding. The company will use the capital to advance its focused ultrasound technology for prostate cancer treatment. The funding round marks a significant investment in the medical device sector.
Tap to vote and see what everyone thinks.
Summary by ByteBrief